Dudley & Shanley Inc. Sells 2,829 Shares of Danaher Corporation $DHR

by · The Cerbat Gem

Dudley & Shanley Inc. trimmed its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 3.8% in the third quarter, Holdings Channel reports. The institutional investor owned 71,195 shares of the conglomerate’s stock after selling 2,829 shares during the period. Danaher makes up 2.5% of Dudley & Shanley Inc.’s holdings, making the stock its 20th biggest holding. Dudley & Shanley Inc.’s holdings in Danaher were worth $15,773,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. Studio Investment Management LLC boosted its holdings in Danaher by 3.3% in the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock valued at $302,000 after purchasing an additional 51 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. JDH Wealth Management LLC raised its stake in Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after acquiring an additional 55 shares in the last quarter. OneAscent Financial Services LLC lifted its position in Danaher by 5.5% in the fourth quarter. OneAscent Financial Services LLC now owns 1,069 shares of the conglomerate’s stock valued at $245,000 after acquiring an additional 56 shares during the last quarter. Finally, Syon Capital LLC lifted its position in Danaher by 0.8% in the fourth quarter. Syon Capital LLC now owns 6,954 shares of the conglomerate’s stock valued at $1,592,000 after acquiring an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

DHR traded down $3.40 during midday trading on Tuesday, reaching $217.81. 1,774,393 shares of the company’s stock were exchanged, compared to its average volume of 4,452,227. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market capitalization of $153.12 billion, a PE ratio of 38.67, a P/E/G ratio of 2.67 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The business’s 50-day moving average price is $209.69 and its 200 day moving average price is $193.88.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the business earned $0.77 earnings per share. The company’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s payout ratio is 28.42%.

Wall Street Analyst Weigh In

Several research firms have commented on DHR. Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. The Goldman Sachs Group increased their price objective on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a report on Monday, September 21st. Piper Sandler started coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price on the stock. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Finally, TD Cowen reduced their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $234.09.

Check Out Our Latest Research Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).